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Brief Description:  
Although diabetes is an extremely common disease both in the U.S. and in other countries, much 
remains to be learned about its relationships with environmental factors, such as stress. This 
study focused on comparing mice injected with low levels of a diabetes-inducing drug and were 
subsequently stressed with those that were not in order to study the effects of stress on the onset 
of diabetes mellitus.  
 
Key Points: 
 
1. Because the drug streptozotocin (STZ) destroys the beta cells of the pancreatic islets, it is 
commonly used to induce diabetes mellitus type 1 in study animals. While stress is 
commonly applied to already diabetic animals, in the present study lower levels of 
streptozotocin were administered and stress was immediately applied to mice even before 
exhibiting diabetic symptoms. 
 
2. Study animals were monitored through glucose measurements taken three times a week 
and bodyweight gain and feed measurements taken twice weekly in order to determine if 
stress advanced or delayed the onset of diabetes mellitus. Cortisol concentrations in the 
blood were measured at the end of the study.  
 
3. Of the three levels of STZ administered (0, 25, 50 mg/kg bodyweight) only the 50 mg 
group exhibited diabetic symptoms. In fact, it was the non-stress 50mg STZ group that 
became diabetic.  
 
4. Statistical analysis of baseline values showed that the animals were randomly assigned to 
treatment groups and no bias existed before the treatments began.  
 
5. Analysis revealed that STZ, stress, and their interaction became statistically significant in 
causing the measurable differences among treatment groups.  
 
 
Key Words: 
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Introduction 
Stress is commonly seen as something to be removed from our lives because of its 
potentially harmful effects on the body. Allostasis is the method the body employs in response to 
stress. Stress can be categorized into two types: acute and chronic. During acute stress the 
hormones cortisol and adrenaline are released, causing increased blood pressure and heart rate 
and heightened immune system and memory, which can be helpful for a short period of time. 
The allostatic load of chronic stress, however, can be detrimental. Stomachaches occur due to 
increased appetite, and therefore weight, and a weakened immune system results.
17
 Blood 
pressure, heart rate, appetite, cholesterol, triglyceride, and blood sugar levels are all increased 
during chronic stress. These are not only risk factors for heart disease, atherosclerosis, stroke and 
obesity, but also diabetes.
17
 
The World Health Organization defined diabetes mellitus as a metabolic disorder of 
multiple origins characterized by chronic hyperglycemia with disturbances of carbohydrate, fat 
and protein metabolism resulting from defects in insulin secretion, insulin action, or both.
1
 
Diabetes mellitus can cause lasting damage, dysfunction and even failure of a variety of organs. 
It sometimes presents with representative symptoms such as polydipsia, polyuria, blurry vision, 
and weight loss. Ketoacidosis or a non-ketotic hyperosmolar state can result from severe forms 
of diabetes, which can lead to stupor, coma, and even death without effective treatment. 
Frequently symptoms are not severe or even absent. As a result, hyperglycemia severe enough to 
cause pathological and functional changes may be present for a substantial amount time before it 
is discovered that the patient is suffering from diabetes mellitus. This disease has multiple long-
term effects including the progressive development of the specific complications of retinopathy 
with potential blindness, nephropathy that possibly results in renal failure, and/or neuropathy 
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with risk of foot ulcers, amputation, Charcot joints, and features of autonomic dysfunction. An 
increased risk of cardiovascular, peripheral vascular, and cerebrovascular disease may also be 
expected. The development of diabetes involves several disease-causing processes, including 
processes which destroy the beta cells of the pancreatic islets, causing insulin deficiency, and 
others that cause resistance to the function of insulin. Deficient insulin function on target tissues 
because of insensitivity or lack of insulin causes the abnormalities of carbohydrate, fat and 
protein metabolism.
1
 
Although forms of insulin problems always exist in diabetes mellitus, there are several 
types of diabetes that have been classified based on the underlying problem which can be 
identified specifically, such as genetic defects of beta-cell function, genetic defects in insulin 
action, diseases of the exocrine pancreas, endocrinopathies, drug- or chemical-induced, 
infections, uncommon forms of immune-mediated diabetes, and other genetic syndromes 
sometimes associated with diabetes. In the other more publicly well-known classifications of 
diabetes, type 1 and type 2, the specific causes for the development of abnormalities remain as 
mysteries.
1
 Diabetes type1was previously known as insulin dependent diabetes mellitus, 
IDDM
1,5
 and type 2 was known as non-insulin dependent diabetes mellitus (NIDDM).
1
 These 
names were dropped in favor of type 1 and 2 in order to ensure patients were classified based on 
pathogenesis rather than treatment. Diabetes type 2 is characterized by the malfunction of insulin 
action or secretion, either of which may be more prevalent, but both are usually seen at the time 
of diagnosis. The category of type 1 includes cases of diabetes occurring as a result of the 
destruction of the beta cells of the pancreatic islets not caused by an underlying condition, such 
as cystic fibrosis. People suffering from diabetes type1are prone to ketoacidosis and can be 
diagnosed at an early stage of the disease, hence its former name juvenile onset diabetes 
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mellitus.
1, 5
 Insulin is a required treatment to prevent ketoacidosis and an impending coma. Type 
1 diabetic patients have anti-glutamic acid decarboxylase (GAD), which is characteristic of this 
form of diabetes. Anti-GAD are islet cell or insulin antibodies that identify the autoimmune 
processes that lead to beta cell destruction.
1
 Diabetes type 1is classified as a chronic autoimmune 
disease. The insulin-producing beta cells, which make up the majority of the pancreatic islets but 
only 2% of the entire pancreas, are destroyed by T cell-mediated autoimmune destruction in 
subjects with a genetic predisposition to this disease.
5, 24
 The resulting insulin deficiency can lead 
to a death which is similar to accelerated starvation. While administration of insulin has 
prevented the majority of these types of deaths, it results in severe hypoglycemia being a 
constant risk for type 1 diabetics.
5
 
Affecting nearly 170 million individuals worldwide, diabetes is already a huge global 
issue and is expected to continue growing. At least 366 million individuals are anticipated to 
receive a diagnosis of diabetes within a future span of 25 years. These are also most likely 
underestimates as they presume obesity levels will remain constant. Although diabetes mellitus 
type 1 only accounts for 5-10 percent of all diabetics, it represents a noteworthy health concern, 
as this disorder begins early in life and leads to continuing health complications.
16
 
Streptozotocin-treated mice are commonly used to model diabetes type1 due to the ability of 
streptozotocin (STZ) to destroy the insulin-producing beta cells of the pancreatic islets of 
Langerhans.
16, 23
 Many studies have been completed on the effects of stress on STZ diabetic mice 
and rats. It is known that STZ-induced diabetic rats have greater sensitivity to stress, as seen 
through increased plasma levels of corticosterone. Some mechanisms between diabetes and 
stress have also been found to be similar: beta-amyloid toxicity is made more potent in the 
hippocampus of rats treated with STZ, HNE protein conjugation, proposed to mediate beta-
 7 
amyloid toxicity, is increased in the hippocampus of diabetic rats subjected to stress,
 23
 and the 
stimulation of morphological changes in the hippocampus have been associated with chronic 
stress.
11
 
Cortisol levels, known to rise in response to stress, are increased in type 1 diabetic 
patients. It has also been found that stress enhances the production of immunosuppressive 
cytokines. Also, psychological stress (restraint stress) has been linked with an increased 
occurrence of infectious disease, which demonstrates that the immunosuppressive actions of 
stress translate into significant adverse health effects.
6
 Changes in STZ-induced diabetic stressed 
rats were attributed to glucocorticoid impairment.
23
 Most research examining the relationship of 
restraint stress and STZ-induced diabetes has been performed on already diabetic animal models. 
In the present study, normal, healthy Swiss ICR mice were exposed to restraint stress and lower 
doses of STZ than normally used to induce diabetes mellitus in mice. Due to the fact that cortisol 
levels rise in response to stress and increase blood glucose levels, we hypothesized that stress 
would accelerate the onset of diabetes mellitus. 
 
However, evidence that stress may delay the onset of diabetes also exists. In one study, it 
was found that light repeated emotional stress hampered development of obesity and diabetes 
type 2 in mice with the Agouti yellow mutation.
3
 In a study using Zucker diabetic fatty rats it 
was found that intermittent restraint and its adaptations delayed hyperglycemia and improved 
glucose control, which may be explained by restraint-induced lowering of food intake and lower 
overall corticosterone exposure with repeated restraint. Ironically, these investigations suggest 
some types of occasional stress may limit development of diabetes.
2
 These, however, are 
examples of stress delaying the onset of diabetes type 2 in obese mice and rats.  
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Materials and Methods 
Experimental procedure 
Sixty-seven 8-week-old mice were housed individually for three days to acclimatize. 
Mice were weighed and the extra mice were excluded on the basis of weight.  
The mice were divided into two groups: Group A and Group B. Group A included mice 
numbered 1-30; group B included mice numbered 31-60. The experiment began with Group A 
and ended 18 days later. Experimentation on Group B began one day after Group A had been 
started. Both groups of mice received injections the first three days of the experiment. The mice 
received treatment as shown in Table 1 according to two factors: stress and streptozotocin (STZ). 
Table 1. Treatment Groups 
Factor 1 Factor 2 
Streptozotocin No Stress Stress 
0 STZ #1-5, 31-35 #16-20, 46- 50 
25 STZ #6-10, 36-40 #21-25, 51-55 
50 STZ # 11-15, 41-45 #26-30, 56-60 
 
Baseline animal weight, feed weight, and glucose levels were taken on D0 for all mice 
and STZ or buffer injections were given.  
Glucose measurements were taken three times a week beginning on D0 for both groups 
using blood glucose meters (FreeStyle Freedom Lite, Catalog number 70914, NDC 99073-0709-
14, Distributed by: Abbott Diabetes Care Inc) and appropriate test strips (Freestyle Lite Blood 
Glucose Test Strips). 
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Mice were weighed twice each week. Feed weight was taken two times per week. Feed 
was refilled and reweighed as needed to calculate food consumption.  
Stressed mice were placed in 50 ml well-ventilated centrifuge tubes packed lightly with 
approved nesting material for 6 hours beginning at approximately the same time each day during 
which time the control mice were free in their cages but without access to feed and water. After 
the 6 hour-period, the treated mice were returned to their cages with access to feed and water and 
the control mice were again given access to feed and water.  
Tissue Collection 
At the end of the 18 days of treatment, mice were euthanized and blood was collected. 
Corticosterone Assay 
The Corticosterone assay was performed according to the method outlined in assay 
designs
© 
Corticosterone Enzyme Immunoassay Kit (Catalog No. 900-097). First, the reagents 
were prepared. Assay Buffer 15 was prepared using a 9 to 1 ratio of distilled water to supplied 
Assay Buffer 15, respectively. Wash buffer was prepared in a similar manner using a 19 to 1 
ratio of distilled water to supplied wash buffer. Separate Corticosterone standards were prepared 
for each plate. The Corticosterone standards were prepared as follows: 900 µL of standard 
diluent (prepared Assay buffer 15) was added to tube #1; 800 µL of standard diluent was added 
to tubes #2 - #5. To tube #1, 100 µL of the provided 200,000 pg/mL standard was added, 
generating standard 1. To tube #2, 200 µL of standard 1 was added, generating standard 2. To 
tube #3, 200 µL of standard 2 was added, generating standard 3. To tube #4, 200 µL of standard 
3 was added, generating standard 4. To tube #5, 200 µL of standard 4 was added, generating 
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standard 5. The concentrations of standards 1 through 5 in pg/mL are 20,000, 4,000, 800, 160, 
and 32, respectively.   
Standards were run in duplicate while samples were run in triplicate. Reagents were 
brought to room temperature and 100 µL of Assay Buffer 15 was pipetted into wells designated 
NSB and Bo. Then 100 µL of Standards 1 through 5 were pipetted into the correct wells. 100 µL 
of samples were pipetted into their designated wells. Into the NSB wells 50 µL of Assay Buffer 
15 was pipetted. Excluding wells designated Total Activity and Blank, 50 µL of blue Conjugate 
was pipetted into each well. Excluding wells designated Blank, Total Activity, and NSB, 50 µL 
of yellow Antibody was pipetted into each well. At this time, NSB wells were blue in color, 
Blank and Total Activity had no color, and every other well used was green.  
The plates were covered with the provided plate sealer and incubated at room 
temperature on a plate shaker for 2 hours. The contents of the wells were dumped and washed 
using wash solution a total of three times. Following the final wash, the plates were tapped 
firmly on a lint free paper towel to remove remaining wash buffer. Next 5 µL of blue Conjugate 
was added to the Total Activity wells. Finally every well received 200 µL of Stop Solution and 
the plates were read.  
Results 
Glucose, bodyweight, and feed consumption analysis using two-way ANOVA and ANCOVA 
Two-way ANOVA, also known as the two-way analysis of variance, is necessary in this 
case because there are two factors: STZ and Stress. The experiment was a factorial one in which 
the response is observed at all factor-level combinations of the independent variables. If the 
factors were expressed as their sum, the sums would be too large because each would have to 
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include the overall mean. Instead, the two-way ANOVA model splits the total variability into 
four sources of variability, which in this case are: the main effects of STZ, the main effects of 
stress, the possible interaction between STZ and stress, and the unexplained variability from all 
sources not accounted for by the main effects and interaction, known as error.
22
 
Total variability is the variability in the response variable among the 60 mice and is 
represented by  
 !!!"# ! !!
!!"
!!!
!
!!!
!
!!! !!                    (1.1) 
In the present study, the variables in the two-way ANOVA model  
Ƴijk = u+αi +βj+ ɣij + eijk              (1.2)  
 are: Ƴ: measurement (ex. glucose level on day 3), U: mean, α: effect of STZ, β: effect of stress, 
ɣ: interaction between them, and e: error, where the subscript i denotes STZ, j denotes stress, and 
k denotes the individual mouse. ANOVA answers the question: At each point, what is the effect 
of the treatment? In order to compare changes among individuals, baseline values were taken: 
measurements taken before any treatments were applied. Baseline measurements were important 
not only to compare changes among individuals, but also to ensure that the independence 
assumption of the two-way ANOVA model was not violated. This was done by checking for 
randomization.
8
  
ANCOVA is another statistical tool that can be used alongside ANOVA in order to better 
control for outside variance. ANCOVA is ANOVA with one or more covariates. One of its 
important uses is to increase precision in randomized experiments. It does this by removing 
variability not due to the experimental treatments themselves. Variables other than those of the 
main scientific interest can be measured and the variability due to them can be partitioned in 
order to better assess the effects due to the variable of scientific interest.
25
 In this case, initial 
 12 
glucose level of the animal is used as a covariate when studying the difference in glucose 
between treatments. In this manner, one could determine if the baseline glucose level is an 
important factor.  ANCOVA is an elegant way of accounting for the effect of baseline glucose 
level when analyzing glucose level for one specific time. The model is similar to 2 Way 
ANOVA with an extra term which is the baseline glucose. 
Yijk=µ + αi+ βj + ɣij+ b*baseline glucose +eijk (1.3) 
ANOVA and ANCOVA GLUCOSE RESULTS 
As seen in the two-way ANOVA of the baseline glucose values, no difference existed 
among the groups. Therefore the mice were randomly assigned to treatments and no bias existed 
at the beginning of the experiment.  
Table 2. Glucose day 0: Raw values 
Two-way ANOVA: glucd0 versus STZ, Stress  
 
Source       DF       SS       MS     F      P 
STZ           2   1015.2  507.617  1.03  0.363 
Stress        1      2.4    2.400  0.00  0.945 
Interaction   2    162.9   81.450  0.17  0.848 
Error        54  26516.4  491.044 
Total        59  27696.9 
S = 22.16   R-Sq = 4.26%   R-Sq(adj) = 0.00% 
 
 
On the 4
th
 day there was still no difference when the raw scores were analyzed (Table 3), 
nor ANCOVA of the 4
th
 day with glucose day 0 as a covariate (Table 4). 
Table 3. Glucose day 4: Raw scores 
Two-way ANOVA: gluc4 versus STZ, Stress  
 
Source       DF      SS       MS     F      P 
STZ           2    4158  2078.87  1.08  0.345 
Stress        1    2802  2801.67  1.46  0.232 
Interaction   2    2241  1120.47  0.58  0.561 
Error        54  103483  1916.36 
Total        59  112684 
 
S = 43.78   R-Sq = 8.16%   R-Sq(adj) = 0.00% 
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Table 4. ANCOVA Glucose day 4 with Glucose day 0 as a covariate   
General Linear Model: gluc4 versus STZ, Stress  
Analysis of Variance for gluc4, using Adjusted SS for Tests 
 
Source      DF  Seq SS  Adj SS  Adj MS     F      P 
glucd0       1    3432    4922    4922  2.65  0.110 
STZ          2    5873    5833    2916  1.57  0.218 
Stress       1    2730    2731    2731  1.47  0.231 
STZ*Stress   2    2087    2087    1044  0.56  0.574 
Error       53   98561   98561    1860 
Total       59  112684 
 
S = 43.1235   R-Sq = 12.53%   R-Sq(adj) = 2.63% 
 
On the seventh day the difference among the different levels of STZ began to become 
significant, although there was no difference yet between stressed and non-stressed mice.  By 
day 7 STZ became significant with a P-value of less than 0.05 meaning that because of the STZ, 
the different groups of mice no longer had the same glucose levels. STZ was also significant on 
day 7 using ANCOVA with glucose day 0 as a covariate.  
Table 5. Glucose day 7: Raw scores 
Two-way ANOVA: gluc7 versus STZ, Stress  
 
Source       DF       SS       MS     F      P 
STZ           2  12734.8  6367.40  4.67  0.013 
Stress        1   1706.7  1706.67  1.25  0.268 
Interaction   2   1917.7   958.87  0.70  0.499 
Error        54  73604.4  1363.04 
Total        59  89963.6 
 
S = 36.92   R-Sq = 18.18%   R-Sq(adj) = 10.61% 
 
 
Table 6. ANCOVA Glucose day 7 with Glucose day 0 as a covariate  
General Linear Model: gluc7 versus STZ, Stress  
 
Analysis of Variance for gluc7, using Adjusted SS for Tests 
 
Source      DF  Seq SS  Adj SS  Adj MS     F      P 
glucd0       1    6654    8150    8150  6.60  0.013 
STZ          2   14362   14352    7176  5.81  0.005 
Stress       1    1636    1636    1636  1.32  0.255 
STZ*Stress   2    1857    1857     929  0.75  0.476 
Error       53   65454   65454    1235 
Total       59   89964 
 
S = 35.1424   R-Sq = 27.24%   R-Sq(adj) = 19.01% 
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The difference was clearer when using ANCOVA with glucose day 0 as a covariate 
because baseline variability was negated. The boxplot below indicates that there was not a large 
difference between the STZ=0 and STZ=25 groups; the group of STZ=50 was the one that 
appeared different with regard to the change in glucose with respect to the baseline values. 
 
Figure 1. Boxplot of Glucose day 7 minus the baseline values
 
 
**** In order to do analysis on days 9, 11, and 14, a glucose level of 501 was assigned to mouse 
42; the glucose meter read “HI” which denoted a glucose level above 500.  
 
On day 9 the difference among the different STZ groups was also statistically significant: 
Table 7. Glucose day 9: Raw scores 
Two-way ANOVA: gluc9 versus STZ, Stress  
 
Source       DF      SS       MS     F      P 
STZ           2   41876  20937.9  7.02  0.002 
Stress        1    3760   3760.4  1.26  0.266 
Interaction   2   18277   9138.7  3.07  0.055 
Error        54  160960   2980.7 
Total        59  224874 
 
S = 54.60   R-Sq = 28.42%   R-Sq(adj) = 21.79% 
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Table 8. ANCOVA Glucose day 9 with Glucose day 0 as a covariate  
General Linear Model: gluc9 versus STZ, Stress  
 
Analysis of Variance for gluc9, using Adjusted SS for Tests 
 
Source      DF  Seq SS  Adj SS  Adj MS     F      P 
glucd0       1   11045   14494   14494  5.24  0.026 
STZ          2   47435   47017   23509  8.51  0.001 
Stress       1    3612    3621    3621  1.31  0.257 
STZ*Stress   2   16316   16316    8158  2.95  0.061 
Error       53  146466  146466    2764 
Total       59  224874 
S = 52.5691   R-Sq = 34.87%   R-Sq(adj) = 27.49% 
 
Through day 9, the ANCOVA models have shown that baseline glucose seemed to be 
important in days 7 and 9 but not in days 2 and 4. 
Figure 2. Boxplot of Glucose day 9 minus the baseline values 
 
 
 
 
The interaction between STZ and Stress was not significant at the 0.05 level but it was 
low enough as to suggest that there was some mild interaction, something that was confirmed by 
the interaction plot. To show the interaction, the treatments were plotted in a single display 
called an interaction plot (Figure 3). This plot showed the average of the observations at each 
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level of one factor broken up by the levels of the other factor.
8
  On day 9, the stressed mice of 
both the 0 and 25mg STZ groups had higher glucose levels than their non-stressed counterparts. 
The opposite is true with the 50 STZ groups.  
Figure 3. Interaction Plot of Glucose day 9 minus baseline values
 
 
On the eleventh day the interaction and the effects of stress and STZ all became 
significant with P-values below 0.005. An interaction was noted when the effects of one factor 
change for different levels of another factor. The interaction plot indicates it is the STZ =50 
group which was the one that had a much higher mean for glucose change from the baseline 
values. However, the STZ affected the mice differently depending if they were stressed or not. 
Surprisingly the stressed mice showed lower levels of glucose. One possible explanation for this 
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is that while the mice were being stressed, they were working to escape, which was a form of 
exercise.
14
 
 
 
Table 9. Glucose day 11: Raw values 
Two-way ANOVA: gluc11 versus STZ, Stress  
 
Source       DF      SS       MS      F      P 
STZ           2  101456  50727.8  19.89  0.000 
Stress        1   18166  18165.6   7.12  0.010 
Interaction   2   33983  16991.5   6.66  0.003 
Error        54  137691   2549.8 
Total        59  291295 
 
S = 50.50   R-Sq = 52.73%   R-Sq(adj) = 48.35% 
 
 
Table 10. ANCOVA Glucose day 11 with Glucose day 0 as a covariate 
General Linear Model: gluc11 versus STZ, Stress  
 
Analysis of Variance for gluc11, using Adjusted SS for Tests 
 
Source      DF  Seq SS  Adj SS  Adj MS      F      P 
glucd0       1    3515    5481    5481   2.20  0.144 
STZ          2  104967  104477   52238  20.94  0.000 
Stress       1   17954   17975   17975   7.21  0.010 
STZ*Stress   2   32650   32650   16325   6.54  0.003 
Error       53  132209  132209    2495 
Total       59  291295 
 
S = 49.9451   R-Sq = 54.61%   R-Sq(adj) = 49.48% 
 
As seen in the interaction plot in Figure 4, the stressed mice that received 0 STZ had a 
higher glucose level than their non-stressed counterparts by day 11. Those in the 25 STZ group 
that were stressed had lower glucose levels than their non-stressed counterparts on day 11, which 
has changed from day 9. 
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Figure 4. Interaction plot for Glucose day 11 minus the baseline values
 
 
A similar behavior was observed in days 14 and 16. Stress P-value was increased by day 14. 
Table 11. Glucose day 14: Raw values 
Two-way ANOVA: gluc14 versus STZ, Stress  
 
Source       DF      SS       MS      F      P 
STZ           2  116397  58198.6  14.18  0.000 
Stress        1   11704  11704.1   2.85  0.097 
Interaction   2   55412  27705.8   6.75  0.002 
Error        54  221709   4105.7 
Total        59  405221 
 
S = 64.08   R-Sq = 45.29%   R-Sq(adj) = 40.22% 
 
Table 12. ANCOVA Glucose day 14 using Glucose day 0 as a covariate  
General Linear Model: gluc14 versus STZ, Stress  
 
Analysis of Variance for glug14, using Adjusted SS for Tests 
 
Source      DF  Seq SS  Adj SS  Adj MS      F      P 
glucd0       1    7438   10373   10373   2.60  0.113 
STZ          2  121918  121237   60618  15.20  0.000 
Stress       1   11473   11494   11494   2.88  0.095 
STZ*Stress   2   53057   53057   26529   6.65  0.003 
Error       53  211336  211336    3987 
Total       59  405221 
S = 63.1464   R-Sq = 47.85%   R-Sq(adj) = 41.94% 
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Figure 5. Interaction Plot for Glucose day 14 minus the baseline values 
 
 
 
Table 13. Glucose day 16: Raw values 
Two-way ANOVA: gluc16 versus STZ, Stress  
 
Source       DF      SS       MS      F      P 
STZ           2  185722  92861.2  28.22  0.000 
Stress        1   14199  14198.8   4.32  0.043 
Interaction   2   44065  22032.5   6.70  0.003 
Error        54  177679   3290.4 
Total        59  421665 
 
S = 57.36   R-Sq = 57.86%   R-Sq(adj) = 53.96% 
 
 
 
Table 14. ANCOVA Glucose day 16 using Glucose day 0 as a covariate  
General Linear Model: gluc16 versus STZ, Stress  
Analysis of Variance for gluc16, using Adjusted SS for Tests 
 
Source      DF  Seq SS  Adj SS  Adj MS      F      P 
glucd0       1    3625    6955    6955   2.16  0.148 
STZ          2  191535  190506   95253  29.57  0.000 
Stress       1   13981   14009   14009   4.35  0.042 
STZ*Stress   2   41800   41800   20900   6.49  0.003 
Error       53  170724  170724    3221 
Total       59  421665 
 
S = 56.7557   R-Sq = 59.51%   R-Sq(adj) = 54.93% 
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The output of ANCOVA again showed what was already known: at day 16 STZ was 
significant, stress was significant, and there was an interaction between STZ and stress. The not 
so small P-value (0.148) for baseline glucose indicated that at day 16 the baseline glucose did 
not really have an effect on the glucose at day 16 but that the treatments caused the difference. 
However, even when non-significant baseline glucose explained a little bit of the differences 
among mice, and the R-square (both regular and adjusted) was a little better for ANCOVA than 
for ANOVA without the covariate. See the output for ANOVA without the covariate. 
By day 16, the interaction plot revealed that the non-stressed mice in both the 0 and 25 
STZ groups had the lowest mean glucose levels. Also, the stressed 25 STZ group had a slightly 
higher mean glucose level than the stressed 0 STZ group.  
 
Figure 5. Interaction plot for Glucose day 16 minus baseline values 
 
 
 
 
 
Table 15. Glucose day 18 
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Two-way ANOVA: gluc18 versus STZ, Stress  
 
Source       DF      SS      MS      F      P 
STZ           2  252472  126236  34.30  0.000 
Stress        1   41082   41082  11.16  0.002 
Interaction   2   84933   42467  11.54  0.000 
Error        54  198727    3680 
Total        59  577214 
 
S = 60.66   R-Sq = 65.57%   R-Sq(adj) = 62.38% 
 
 
Table 16. Glucose day 18 using Glucose day 0 as a covariate 
 
General Linear Model: gluc18 versus STZ, Stress  
Analysis of Variance for gluc18, using Adjusted SS for Tests 
 
Source      DF  Seq SS  Adj SS  Adj MS      F      P 
glucd0       1    4280    9980    9980   2.80  0.100 
STZ          2  261177  259795  129898  36.47  0.000 
Stress       1   40642   40687   40687  11.42  0.001 
STZ*Stress   2   82358   82358   41179  11.56  0.000 
Error       53  188750  188750    3561 
Total       59  577207 
 
S = 59.6768   R-Sq = 67.30%   R-Sq(adj) = 63.60% 
 
The interaction plot below indicates that for the mice who received 0 or 25mg/kg STZ 
there was not a major difference in mean glucose between the stressed and non-stressed mice, 
but there was a big difference for those who received 50mg/kg STZ. Actually the non-stressed 
mice had higher mean glucose. 
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Figure 6. Interaction of STZ and Stress on Glucose
 
*** Due to lack of glucose testing strips, glucose measurements were not taken for mouse 48 on 
day 18. In order to run ANOVA the average glucose value (147) was used for mouse 48. 
 
ANOVA BODYWEIGHT RESULTS 
The baseline bodyweight also showed randomization, as the P-values for STZ, stress, and 
their interaction were insignificant. By day 18, STZ and stress were significant factors in the 
differences of bodyweight among the groups.  
Table 17. Bodyweight day 0: Raw values 
Two-way ANOVA: bwgd0 versus STZ, Stress  
 
Source       DF       SS       MS     F      P 
STZ           2    3.133  1.56650  0.59  0.558 
Stress        1    0.793  0.79350  0.30  0.587 
Interaction   2    1.677  0.83850  0.32  0.731 
Error        54  143.513  2.65765 
Total        59  149.117 
 
S = 1.630   R-Sq = 3.76%   R-Sq(adj) = 0.00% 
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Table 18. Bodyweight day 4: Raw values 
Two-way ANOVA: bwgd4 versus STZ, Stress  
 
Source       DF       SS       MS     F      P 
STZ           2   33.334  16.6672  4.90  0.011 
Stress        1   28.843  28.8427  8.49  0.005 
Interaction   2    1.090   0.5452  0.16  0.852 
Error        54  183.526   3.3986 
Total        59  246.793 
 
S = 1.844   R-Sq = 25.64%   R-Sq(adj) = 18.75% 
 
Table 19. Bodyweight day 8: Raw values 
Two-way ANOVA: bwgd8 versus STZ, Stress  
 
Source       DF       SS       MS      F      P 
STZ           2   34.137  17.0685   4.07  0.023 
Stress        1   58.214  58.2135  13.88  0.000 
Interaction   2    1.267   0.6335   0.15  0.860 
Error        54  226.399   4.1926 
Total        59  320.017 
 
S = 2.048   R-Sq = 29.25%   R-Sq(adj) = 22.70% 
 
 
Table 20. Bodyweight day 11: Raw values 
Two-way ANOVA: bwgd11 versus STZ, Stress  
 
Source       DF       SS       MS      F      P 
STZ           2   39.232  19.6162   4.52  0.015 
Stress        1   53.016  53.0160  12.21  0.001 
Interaction   2    1.129   0.5645   0.13  0.878 
Error        54  234.480   4.3422 
Total        59  327.857 
 
S = 2.084   R-Sq = 28.48%   R-Sq(adj) = 21.86% 
 
Table 21. Bodyweight day 15: Raw values 
Two-way ANOVA: bwgd15 versus STZ, Stress  
 
Source       DF       SS       MS      F      P 
STZ           2   50.317  25.1585   5.81  0.005 
Stress        1   49.141  49.1415  11.35  0.001 
Interaction   2    2.899   1.4495   0.33  0.717 
Error        54  233.839   4.3304 
Total        59  336.197 
 
S = 2.081   R-Sq = 30.45%   R-Sq(adj) = 24.01% 
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Table 22. Bodyweight day 18: Raw values 
Two-way ANOVA: bwgd18 versus STZ, Stress  
 
Source       DF       SS       MS      F      P 
STZ           2   49.948  24.9740   5.43  0.007 
Stress        1   84.728  84.7282  18.42  0.000 
Interaction   2    3.033   1.5167   0.33  0.721 
Error        54  248.447   4.6009 
Total        59  386.156 
 
S = 2.145   R-Sq = 35.66%   R-Sq(adj) = 29.70% 
 
 
ANOVA FEED WEIGHT CONSUMPTION RESULTS 
 
The P-values indicate randomization in the beginning of the experiment. However, STZ, 
stress, and their interaction never became statistically significant. 
 
Table 23. Feed Consumption day 8: Raw values 
Two-way ANOVA: fc8 versus STZ, Stress  
 
Source       DF       SS       MS     F      P 
STZ           2    401.6   200.81  0.53  0.591 
Stress        1   1311.3  1311.34  3.46  0.068 
Interaction   2    436.7   218.34  0.58  0.565 
Error        54  20441.6   378.55 
Total        59  22591.2 
 
S = 19.46   R-Sq = 9.52%   R-Sq(adj) = 1.14% 
 
 
 
Table 24: Feed Consumption day 18: Raw values 
Two-way ANOVA: fc18 versus STZ, Stress  
 
Source       DF      SS       MS     F      P 
STZ           2    3134  1567.18  0.88  0.422 
Stress        1    4333  4333.30  2.42  0.125 
Interaction   2    2215  1107.67  0.62  0.542 
Error        54   96573  1788.39 
Total        59  106256 
 
S = 42.29   R-Sq = 9.11%   R-Sq(adj) = 0.70% 
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Table 25: Feed Consumption day 18 minus baseline values 
Two-way ANOVA: fc18-8 versus STZ, Stress  
 
Source       DF       SS       MS     F      P 
STZ           2   1591.4  795.687  1.21  0.307 
Stress        1    877.1  877.073  1.33  0.254 
Interaction   2    757.7  378.862  0.57  0.566 
Error        54  35617.7  659.586 
Total        59  38843.8 
 
S = 25.68   R-Sq = 8.31%   R-Sq(adj) = 0.00% 
 
 
 
Repeated Measures Analysis 
 
Data sets with multiple measurements of a response variable on the same experimental 
unit are known as repeated measures. The multiple measurements are usually made over a period 
of time but can also be over a physical space. A completely randomized experimental design 
with data collected in a sequence of equally spaced points in time is required in order for 
repeated measures to be applied. Treatments and time are the two factors and repeated measures 
experiments have a factorial design. How treatment means change over time and how treatment 
differences change over time are the main focus questions of repeated measures analysis.  The 
covariance structure of the observed data differentiates the repeated measures model from others. 
Comparing treatment means or treatment regression curves over time are the aims. There are 
three general types of statistical analyses often used for repeated measures. The method used in 
the present study applies methods based on the mixed model with special parametric structure on 
the covariance matrices. This type is applied in PROC MIXED with SAS.
15
 In the present study, 
stress (yes or no) and STZ (0, 25, or 50) were fixed effects factors because the interest was in 
those specific levels. Mouse was a random effect because the interest was not in the specific 
individual mice but only as they pertained to a sample of all mice, which is the reason the 
procedure is called MIXED (mixture of fixed effects and random effect factors). 
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The SAS output for the mixed model using the following equation is below:  
 
Glucoseijkm= u-STZi +stressj+STZ*sẏ + day + STZ*day+s*day+STZ*s*day+eijkm       (1.3) 
 
Table 26. PROC MIXED 
    Num    Den 
  Effect                  DF       DF           Chi-Square   F Value     Pr > ChiSq   Pr > F 
 
  STZ                  2       54         51.00      25.50        <.0001    <.0001 
  Stress               1       54         7.07        7.07         0.0078    0.0103 
  STZ*stress      2       54         17.33      8.66         0.0002    0.0005 
  Day                  8       432        81.19     10.15         <.0001    <.0001 
  STZ*day          16     432        80.25      5.02         <.0001    <.0001 
  Stress*day         8       432        15.01      1.88         0.0590    0.0620 
  STZ*stress*day     16     432         35.62      2.23         0.0033    0.0043 
 
 
Cov Parm     Subject    Estimate 
 
  AR(1)        mouse        0.6459 
 
Similar to the ANOVA results, the repeated measures model showed that Stress, STZ, 
and their interaction were significant factors in causing the differences among the six treatment 
groups. 
 
Longitudinal Analysis  
The method of longitudinal analysis centers on analyzing response profiles that can be 
applied to data which occurs throughout time when the design is balanced. Although all subjects 
are measured the same set of times, longitudinal analysis is capable of handling missing data. 
The data can be condensed by the estimated mean response at each time, stratified by levels of 
the group factor. The mean response profile is the sequence of means over time at any given 
level of the group factor. The plots are created when the program (Minitab in the present study) 
calculates the arithmetic average of the responses at each time, within each treatment group, and 
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joins adjacent means with a series of line segments. The purpose in analyzing response profiles is 
to characterize the patterns of change in the mean response over time in the groups and to 
determine whether the shapes of the mean response profiles are different when comparing 
different treatment groups. Longitudinal analysis looks at the way the variable changes with time 
and the way factors affect that change.
9
 
 In longitudinal studies, the presence of a baseline measurement is critical as it can be 
assumed not rely on treatment group. One can adjust for baseline depending on the scientific 
question that is to be answered by the study. When the main goal of the study is to compare 
groups in terms of their average change over time, the analysis that subtracts baseline response is 
suitable. This method may be used on observations and randomized trials. The analysis of 
covariance may also be used on randomized trials and may offer a more effective test of group 
differences.
9
 
 When viewing response profile plots, there are three questions to keep in mind: 1) Are 
the mean response profiles similar in groups, in the sense that they are parallel? 2) If they are 
parallel, are they constant over time so that the mean response profiles are flat? 3) If they are 
parallel, are the mean response profiles also overlapping? The main scientific interest is in 
answering the first question. In fact, the last two questions are only asked if the first question is 
answered positively. If the response profiles are parallel, then all groups change in the same 
manner across time, regardless of treatment group.
9
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INDIVIDUAL RESPONSE PROFILES: GLUCOSE 
The data was plotted for the individual mice throughout the days and for each treatment 
group.  In both 0 STZ groups (Figure 6 and 7) there was variability among mice and among days 
for the same mouse but no trend was present. 
Figure 6. Individual Response Profile: 0 STZ, non-stress
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Figure 7. Indifidual Response Profile: 0 STZ, stress
 
As with the 0 STZ groups, variability was seen among mice and days, but no trend was present. 
 
 
 
 
 
 
 
 
 
 
 
 
 30 
Figure 8. Individual Response Profile: 25 STZ, Stress 
 
Figure 9. Individual Response Profile: 25 STZ, Non-stress
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 In the 50 STZ stress group, two mice seemed to have an upward trend. Overall, however 
the plot was flat with slight variability.  
Figure 10. Individual Response Profile: 50 STZ, Stress
 
 
In the STZ=50 and non-stress groups, a clear upward trend in glucose beginning around 
the 7
th
 day was present. Comparing different groups, there was no clear difference in the first 
days; it was around the 7
th
 day that the difference among groups began.  
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Figure 11. Individual Response Profile: 50 STZ, Non-stress 
 
INDIVIDUAL RESPONSE PROFILES: BODYWEIGHT   
As seen in Figures 12- 13 the bodyweight of the non-stressed mice increased steadily overall. 
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Figure 12. Individual Response Profile: 0 STZ, Non-Stress
 
Figure 13. Individual Response Profile: 25 STZ, Non-Stress 
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Figure 14. Individual Response Profile: 50 STZ, Non-Stress 
 
 The bodyweight of the 0 STZ stressed group dipped slightly before it began to steady out 
or slightly increase.  
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Figure 15. Individual Response Profile: 0 STZ, Stress
 
Some mice in the 25 STZ stress group lost weight in the beginning before stabilizing. 
Other mice seemed to grow from the beginning.  
 36 
Figure 16. Individual Response Profile: 25 STZ, Stress
 
 All mice in the 50 STZ stress group markedly lost weight in the beginning before 
stabilizing or increasing. There was very little variability in this group.  
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Figure 17. Individual Response Profile: 50 STZ, Stress
 
 
INDIVIDUAL RESPONSE PROFILES: FEED CONSUMPTION 
 As seen in the plot of individual response profiles for the 0 STZ non-stressed group in 
Figure 18 below, feed consumption increased for all mice from the beginning. Other than two 
individual mice, there was very little variability and the response profiles were parallel. 
Similarly, in the 0 STZ stressed group the profiles were also increasing and parallel.  
 The response profiles for both the stressed and non-stressed 25 STZ groups (Figure 20 
and 21) increased with very little variability. The 50 STZ stressed group also followed this trend 
(Figure 22), while the profile for the 50 STZ non-stressed group was more similar to the 0 STZ 
non-stressed group with three mice which consumed much more than the rest. However, the 
profiles were still relatively parallel as these mice were consuming more from the beginning.  
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Figure 18. Feed Consumption Individual Response Profile: 0 STZ, Non-stress
 
Figure 19. Feed Consumption Individual Response Profile: 0 STZ, Stress
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Figure 20. Feed Consumption Individual Response Profile: 25 STZ, Non-stress 
 
Figure 21. Feed Consumption Individual Response Profile: 25 STZ, Stress 
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Figure 22. Feed Consumption Individual Response Profile: 50 STZ, Non-stress 
 
Figure 23. Feed Consumption Individual Response Profile: 50 STZ, Stress 
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GROUP RESPONSE PROFILES 
 While the other mean glucose levels remained relatively stable, it was evident that the 
glucose levels of the 50 STZ non-stress group climbed throughout the study. The glucose levels 
of the 50 STZ stress group increased only slightly.  
Figure 24. Group Response Profile: Glucose Means 
 
 As seen in Figure 24, the response profile using medians was similar to the response 
profile using means. The 50 STZ non-stress group still had the greatest increase in glucose 
levels. The 50 STZ stress group still had the second highest levels, although all groups other than 
50 STZ non-stress seemed to be parallel.  
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Figure 25. Group Response Profile: Glucose Medians
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Viewing the group response profiles in separate panels (Figure 25), it was easy to see that 
the glucose levels increased dramatically in the 50 STZ non-stress group while the glucose levels 
of other treatment groups remained stable.  
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Figure 26. Glucose Group Response Profiles: In separate panels
 
The scatterplot of the 50 STZ non-stress group revealed that the glucose levels increased 
as time progressed. The variability also increased with time.                                      
Figure 27. Scatterplot of Glucose 50 STZ non-stress group
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All treatment groups except 0 STZ and 25 STZ non-stress groups lost weight in the 
beginning before growing. The 50 STZ non-stress group lost the most weight and remained the 
lightest. It is also important to note that very little variability existed among groups on day 0 
compared with day 18.   
Figure 28. Group Response Profiles: Bodyweight
 
 In the group response profiles for feed consumption below, it was evident that although 
there was more variability among groups on day 18 than the beginning, the profiles remained 
parallel.   
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Figure 29. Group Response Profiles: Feed Consumption
 
Principal Components Analysis  
Principal components analysis is a standard method of multivariate analysis applied in 
this case in the context of repeated measurements. The idea is to reduce dimensionality, i.e. the 
number of variables. The individuals were measured 9 times and there is a lot of variability 
among individuals in part because they received different treatments. The purpose of principal 
components analysis is to summarize the 9 measurements taken in the present study into two or 
three principal components that are functions of the 9 measurements. The principal components 
are calculated based on the eigenvalues of the correlation matrix. In the case of glucose, the 
coefficients given to each measurement by the first 3 principal components are: 
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Table 27. Glucose Principal Components 
Variable PC1 PC2 PC3 
Glucose d0 0.087   -0.694   -0.366 
Glucose d2 -0.112 -0.695    0.364 
Glucose d4 0.266 0.036   -0.591 
Glucose d7 0.347   -0.168   -0.223 
Glucose d9 0.395    0.064   -0.231 
Glucose d11 0.407    0.024    0.177 
Glucose d14 0.409    0.024    0.176 
Glucose d16 0.392   -0.023    0.298 
Glucose d18 0.381   -0.012    0.361 
 
Principal Component Analysis: glucd0, gluc2, gluc4, gluc7, gluc9, gluc11, gluc18  
Eigenanalysis of the Correlation Matrix 
Eigenvalue  5.2893  1.2516  1.0913  0.5865  0.3247  0.1674  0.1395  0.0834 
Proportion   0.588   0.139   0.121   0.065   0.036   0.019   0.015   0.009 
Cumulative   0.588   0.727   0.848   0.913   0.949   0.968   0.983   0.993 
Eigenvalue  0.0663 
Proportion   0.007 
Cumulative   1.000 
 
This analysis reveals that the first principal component captures 58.8% of the variability 
among individuals, the first 3 principal components capture almost 85%.  
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Below is a graph of the coefficient for the first principal components. The first principal 
component makes a weighted average of all the measurements (with more weight starting in the 
4
th
 principal component, which is the 7
th
 day) and contrasts that average with the first 
measurement after the treatments began. 
Figure 30. Scatterplot of Coefficient of 1
st
 Principal component 
 
 
The principal components were calculated for all 60 individual mice and their scatterplots 
are plotted below. It is evident that the mice that received 50 STZ stand out, especially those that 
were not stressed. The mice in the other treatment groups are mixed together. 
As seen in the plots below, the 50 STZ non-stress group (except for two mice) stands out 
because of the first principal component, which means that the difference between an average of 
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the last observations with the first one takes different values for them than for the rest of the 
groups. 
Figure 31. Scatterplot of 3
rd
 Principal Component vs. 1
st
 Principal Component  
 
 
Figure 32. Scatterplot of 2
nd
 Principal Component vs. 1
st
 Principal Component  
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Correlations: Bodyweight and Glucose  
Below are the correlations between bodyweight and glucose on day 18 for the 50 STZ 
non- stress (Figure 33) and stress (Figure 34) groups. The correlations were not strong, however 
a negative trend was observed: higher glucose, lower weight.  
For the STZ =50 stress group Pearson correlation gluc18 and bwgd18 = -0.593 
For the STZ=50 non stress group Pearson correlation gluc18 and bwgd18 = -0.326 
 
Figure 33. Bodyweight and Glucose Correlations: Day 18 50 STZ No stress 
 
 
Figure 34. Bodyweight and Glucose Correlations: Day 18 50 STZ Stress
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Corticosterone Results 
ANOVA 
The two-way ANOVA indicated that STZ was what made a difference, and that there 
seemed to be no effect of stress or interaction between STZ and stress.  The low R
2
 indicated that 
only a low portion (18%) of the variability among mice was explained by STZ and stress. 
However, it is known that ANOVA is sensitive to the presence of outliers which were present in 
this experiment. Mouse 42 for example was the far right point on the dotplot below. 
Table 28. Cortisol vs. STZ, Stress 
Two-way ANOVA: cortisol versus STZ, Stress  
 
Source       DF          SS        MS     F      P 
STZ           2   162764224  81382112  4.28  0.019 
Stress        1    39771171  39771171  2.09  0.154 
Interaction   2    22613815  11306908  0.59  0.555 
Error        54  1026465712  19008624 
Total        59  1251614922 
 
S = 4360   R-Sq = 17.99%   R-Sq(adj) = 10.40% 
 
 
Figure 35. Corticosterone Dotplot  
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There was a lot of variability among the individuals but stress and STZ together explain 
only 18% of that variability. The individual value plot below indicates that there was no 
difference in corticosterone levels between the 0 STZ stress and non-stress groups. The 
difference was due to STZ (as seen in the ANOVA results).  
Figure 36. Individual Value Plot: Corticosterone concentration vs. STZ and Stress
 
 
Discussion 
Diabetes type 1 can be particularly devastating due to the fact that it results in life-long 
health complications. These complications occur throughout the body and involve the 
cardiovascular, renal, and nervous systems. Diseases of the nervous system can prove to be more 
devastating as they affect sensitive cognitive regions of the brain, such as the hippocampus that 
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modulates memory function, resulting in significant functional impairment and dementia.
16 
Approximately 40% of DM type 1 disease susceptibility is considered to be a result of genetic 
elements, as revealed through studies in twins, where less than half of identical twins both 
develop the disease. The short arm of chromosome 6 and regions of chromosome 11 contain the 
genetic associations with DM type 1, specifically in the region of human leukocyte antigen 
(HLA) molecules, known as IDDM1. However, some of the regions that have been identified 
exert only a small influence and the precise genes remain unknown in humans.
20
 
In some studies it has been suggested that the incidence of diabetes may vary depending 
upon environmental factors such as stress.
10
 In the study by Fitzpatrick and others, serum 
glucocorticoid concentrations in basal and stress conditions were measured in non-obese diabetic 
mice and C57BL/6 control mice. It was found that the diabetic mice generally exhibited a higher 
corticosterone response than the controls.
10
 In the present study, STZ was found to be the source 
of the difference in corticosterone levels among the different groups, as evidenced by the two-
way ANOVA results. The R
2
 value indicated that only 18% of variability among mice was 
explained by STZ and stress. However, ANOVA is sensitive to the presence of outliers, which 
existed in the present experiment as seen in the dot plot and individual value plot of 
corticosterone versus STZ and stress (Figure 35 and 36). These observations are in agreement 
with previous findings that STZ-induced diabetes elevates levels of serum corticosterone.
21, 19
 
Another study that also observed high resting levels of plasma corticosterone in diabetic rats took 
these observations to suggest that diabetic rats were in a chronic stress condition.
7
 Interestingly, 
in the present study the non-stressed 25 and 50 STZ mice had higher glucose levels but the 
stressed 25 and 50 STZ mice on the individual value plot have higher corticosterone levels. 
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Many studies have researched the effects of stress on already diabetic mice and rats.
2, 3, 10, 
12, 13, 18, 23
 Reagan and others
23
 examined the neurological changes induced by 7 days of restraint 
stress in STZ diabetic rats and found that the hippocampus of diabetic rats was extremely 
susceptible to stress. This research group reported that diabetic rats showed dendritic atrophy of 
pyramidal neurons, increased GLUT3 mRNA and protein expression in the hippocampus, and 
stress additionally caused an increase of the IGF (insulin-like growth factor) receptor in the 
hippocampus.
23
 In a study by Korolkiewicz and others,
13
 using rats made diabetic by a single 
70mg/kg STZ injection 5 weeks prior to the experiment, it was found that stressful stimuli such 
as food deprivation and cold challenge contributed to the elevated susceptibility of diabetic 
gastric mucosa to damage.
13
 Bazhan and others
3
 found that light repeated emotional stress 
decreased the development of obesity and diabetes type 2 in mice with the Agouti yellow 
mutation.
3
 Using borderline, overt, or severe diabetic mice induced by STZ, Meehan and others
18
 
studied glycemic responses of mice to the stress of a resident-intruder encounter and stress of 
blood drawing from the retro-orbital sinus. They found that plasma glucose elevation in overtly 
and severely diabetic mice is not as specific to behavior as in nondiabetic mice.
18
 Bates and 
others
2 
found that intermittent restraint and its adaptations delayed hyperglycemia and improved 
glucose control in Zucker diabetic fatty rats, which may be explained in part by the finding that 
repeated stress lowered overall corticosterone exposure. This investigation concluded that these 
findings suggest some types of occasional stress may limit development of diabetes.
2
 These 
findings are similar to what was observed in the present study. In the present study mice were 
injected with low levels of a diabetes-inducing drug, streptozotocin (STZ). Half of the mice were 
then stressed to determine if stress accelerates the onset of diabetes mellitus. In order to subject 
mice to chronic stress, in the present study, mice were subjected to restraint stress for 6 hours per 
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day for 17 days. This was in line with the study of Gao and others
11
 who considered restraint 
stress for 6 hours per day for 21 days to be chronic stress while one time 6-hour restraint was 
considered acute stress.  
In the present study, the baseline values for glucose versus STZ, stress, and their 
interaction were not significant as evidenced by the two-way ANOVA results (Table 2). This 
was an important foundation as it meant that there was no bias among treatment groups before 
treatments began. Glucose day 4 values using ANOVA and ANCOVA values with glucose day 0 
as a covariate contained no significant P-values. By day 7, both the ANOVA and ANCOVA P-
values for STZ became significant: the treatment groups had different glucose concentrations due 
to the STZ. This observation is inline with previous research,
 19
 in which one week after STZ 
injection defined mice as diabetic when they exhibited plasma glucose greater than 300mg/dl.
19
 
The boxplot of glucose day 7 minus the baseline values (Figure 1) showed that the mean glucose 
levels were almost the same for the 0 and 25 STZ groups while the mean for the 50 STZ group 
was higher. The 25 STZ group had the least variation for most of the mice but had three outliers. 
As seen in the ANOVA and ANCOVA results of glucose day 9, the interaction between STZ and 
Stress was not significant at the P<0.05 level. However, it was low enough as to suggest that 
there was some mild interaction, which was confirmed by the interaction plot (Figure 3). This 
plot shows the average of the observations at each level of one factor broken up by the levels of 
the other factor.
8
 On day 9, the stressed mice of both the 0 and 25 STZ groups had higher 
glucose levels than their non-stressed counterparts. The opposite is true with the 50 STZ groups. 
Surprisingly the 50 STZ stressed mice exhibited lower levels of glucose. One possible 
explanation for this is that while the mice were being stressed, they were working to escape, 
which was a form of exercise. Previous research by Kosovskii and others
14 
comparing types of 
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stress and the development of diabetic syndrome found that mice stressed through cavitary 
operation exhibited the signs of diabetes while those stressed through suspension by nape of neck 
did not. They suggested that the differences could be attributed to the fact that cavitary operation 
resulted in limited mobility while mice stressed by suspension had increased movement while 
trying to escape.
14
 By day 11 STZ, stress, and their interaction were significant in ANOVA and 
ANCOVA (Table 9 and 10). This was not extremely atypical in comparison with one study 
which found that using a low-dose STZ regimen of 50 mg/kg STZ injected intraperitoneally for 5 
consecutive days in fasted mice produces hyperglycemia within 2 weeks of the low-dose STZ 
regimen.
4
 In the interaction plot for glucose day 11 minus baseline values (Figure 4) the non-
stressed 50 STZ mice still have drastically higher glucose levels than the 50 STZ stressed mice. 
The stressed mice that received 0 STZ had a subtly higher glucose level than their non-stressed 
counterparts. The 25 STZ stressed mice had subtly lower glucose levels than their non-stressed 
counterparts, which was a change from day 9. Possibly, the 25 STZ non-stress group had a 
higher mean glucose for the same reason as the 50 STZ non-stress group. It is logical that the 0 
STZ stressed group had a higher mean glucose level than the 0 STZ non-stressed group as stress 
is known to increase glucose levels in the blood.
17
 Perhaps without the interaction of STZ, the 0 
STZ groups show the default reaction of the body to stress, which is an increase in corticosterone 
levels that in turn increase blood glucose levels. In ANOVA and ANCOVA values for day 14 
(Table 11 and 12) STZ remained significant while the P-values for stress returned to non-
significant. By day 16, both STZ and stress once again were significant. Their interaction was 
also significant with a P-value of 0.04 (Table 13 and14). The interaction plot for glucose day 16 
minus the baseline values show that the 0 and 25 STZ non-stressed groups had the lowest mean 
glucose values and were basically the same mean, while the 25 STZ stressed group had a slightly 
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higher mean glucose level than the 0 STZ stressed group. Stress, STZ, and their interaction were 
again significant in the ANOVA and ANCOVA results for glucose day 18 (Table 15 and16). 
Again for the interaction plot for glucose day 18 there was not a huge difference between the 
mean glucose levels in the 0 and 25 STZ groups: they were both relatively low. The 25 STZ non-
stressed group had higher mean glucose levels than the 0 STZ non-stressed group, while it was 
the opposite between the stressed groups: the 0 STZ group had a higher mean glucose than the 
25 STZ group. The markedly different 50 STZ groups remained the same: the non-stressed group 
had the highest mean glucose levels while those of the stressed group were much lower. It is 
interesting to note that previous research has found that as the course of streptozotocin-induced 
diabetes progressed, blood sugar levels became increasingly responsive to the process of 
obtaining the blood samples, i.e., animals sampled later in a given time period had higher blood 
glucose levels.
12
 
Similar to the ANOVA results, the repeated measures model showed that STZ, stress, and 
their interaction were significant factors in causing the differences among the six treatment 
groups. The ANOVA analysis studies the effect of STZ, stress and their interaction one day at 
the time. For some of the days (starting at day 7) there were significant differences and 
interactions contrary to what happened during the first days of the experiment. The repeated 
measures models is more global and analyzes the data for all the days  and therefore finds out 
that the effect of STZ, stress and their interaction are significant. In the glucose individual 
response profiles, variability was present among mice and days, but no clear trend was present in 
the stress and non-stress 0 and 25 STZ groups. In the 50 STZ stress group two mice seemed to 
have an upward trend in glucose levels, while in the 50 STZ non-stress group an upward trend 
was present for practically all of the mice (Figure 11). This trend was also evident in the glucose 
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group response profiles using means and medians (Figure 24, 25). The 50 STZ non-stress group 
still had the greatest increase in glucose levels. The 50 STZ stress group still had the second 
highest levels, although all groups other than 50 STZ non-stress seemed to be parallel. This 
difference among groups was also verified when using principal components. The 50 STZ non-
stress group stood out because of the first principal component. The first principal component 
captured 58.8% of the variability among individuals; the first 3 principal components captured 
almost 85%.  
The baseline two-way ANOVA body weight results showed randomization, as the P-
values for STZ, stress, and their interaction were insignificant. STZ and stress became significant 
as early as day 4 and remained so through day 18. The interaction of STZ and stress never 
became significant. As seen in the body weight group response profile (Figure 28), stress seemed 
to have made all of the animals lose weight initially, as only the 0 STZ and 25 STZ non-stress 
groups did not lose weight up to day 4. Previous research has observed that body weight 
significantly decreases as the diabetic state develops in STZ-injected mice.
19
 The interaction of 
STZ and stress was insignificant because the bodyweight group profiles of the 0 and 25 STZ 
stress group and the 50 STZ non-stress group were parallel and overlapping. The higher dose of 
STZ caused a decrease in bodyweight as did stress for the lower dose or absence of STZ. The 
individual response profiles for bodyweight basically followed the same pattern. Most of the 0 
and 25 STZ non-stress mice gained weight from the beginning. There was slightly less 
variability between mice in the 0 STZ group than the 25 STZ non-stress group. Most of the mice 
in the 50 STZ non-stress group appeared not to lose or gain weight initially except for one mouse 
that drastically lost weight until day 16. This mouse also had the highest blood glucose levels 
throughout the study. Many of the mice in the 0 and 25 STZ stress groups lost weight at the 
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beginning. All of the mice in the 50 STZ stress group markedly lost weight in the first 4 days. 
This group exhibited the least variability as the response profiles were parallel and tightly 
stacked. The correlations between bodyweight and glucose on day 18 for the 50 STZ non- stress 
(Figure 33) and stress (Figure 34) groups were not strong (-0.593, -.0326), however, a negative 
trend was observed: higher glucose, lower weight. This could be due to the findings that a 
symptom of diabetes is weight loss.
23
  
The insignificant P-values for feed consumption in the beginning of the study indicate 
randomization of groups. However, STZ, stress, and their interaction never became statistically 
significant. Knowing that there were differences in bodyweight, it was interesting that there were 
no differences in feed consumption. The individual response profiles showed an increase in feed 
consumption throughout the 18 days for all groups. Overall, the stress groups tended to have less 
variability, with the greatest variability arising in the 0 and 50 STZ non-stress groups. The fact 
that feed consumption did not vary across groups was seen even more clearly through the group 
response profile. Feed consumption increased for all groups in the same way as the profiles were 
parallel.  
Finally, although stress has been shown to suppress the immune system in some instances 
in mouse models and decrease resistance against diseases such as herpes simplex, polio, 
Coxsackie B, and polyoma virus infection,
 12
 the present study suggests that some types of stress 
may actually attenuate the onset of diabetes mellitus type 1 in mice. This is in agreement with 
observations of Huang and others who stressed STZ injected mice through shock stimulation and 
found that none of the 10 mice stimulated beginning 1 h after STZ injection developed diabetes 
mellitus type 1. However, the 9 nonstimulated mice developed hyperglycemia between 6 and 8 
weeks after STZ injection and all had become diabetic by the end of the experiment.
12
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